Pharmacokinetics of Methyl Parathion: A Comparison following Single Intravenous, Oral or Dermal Administration

Abstract

Assessment of the risks posed by the residential use of methyl parathion requires an understanding of its pharmacokinetics after different routes of exposure. Thus, studies were performed using adult female rats to define the pharmacokinetic parameters for methyl parathion after intravenous injection and to apply the described model to an examination of its pharmacokinetics after single oral or dermal exposure. The pharmacokinetics of methyl parathion after intravenous administration (1.5 mg/kg) were best described by a three-compartment model; the apparent volume of the central compartment was 1.45 liters/kg, clearance was 1.85 liters/h/kg and the terminal half-life was 6.6 h with an elimination constant of 0.50 h^–1. The apparent oral absorption coefficient for methyl parathion (1.5 mg/kg) was 1.24 h^–1, and its oral bioavailability was approximately 20%. The latter likely includes a significant first pass effect. Concentrations of methyl parathion increased during the initial 10–60 min and then declined during the next 15–36 h. After dermal administration (6.25–25 mg/kg), methyl parathion concentrations peaked within 12–26 h and then declined dose dependently. The apparent dermal absorption coefficient was approximately 0.41 h^–1, and only two pharmacokinetic compartments could be distinguished. In conclusion, the pharmacokinetics of methyl parathion are complex and route dependent. Also, dermal exposure, because of sustained methyl parathion concentrations, may pose the greatest risk.

Effects of model organophosphorous pesticides on DNA damage and proliferation of HepG2 cells

“…Toxicokinetic studies in rats exposed to a single dose (10 mg/kg) of PT showed that it accumulated in fat tissue (67 lg/mL) and also in some other organs, including the liver (706 ng/mL) [Abu-Qare et al, 2000]. Another study showed that PT was detectable in rat liver after 1 hr of exposure [Kramer et al, 2002]. These studies showed that the concentration of OPs in liver is much higher than in plasma.…”

Heliomycin: Evaluation of its In Vivo Pharmacokinetics in Rats

“…injection and determined using a standard method with linear and log-linear least squares regression analysis to determine the various parameters (Kramer et al 2002;Watanabe et al 1986). The area under the concentration versus time curves from time zero to infinity (AUC 0- ) was calculated by the trapezoidal rule, with extrapolation to infinity by dividing the last measurable blood concentration by the elimination rate constant (β).…”

Motor functions but not learning and memory are impaired upon repeated exposure to sub-lethal doses of methyl parathion

“…The studies on pharmacokinetics of MP through different routes of exposure suggested dermal exposure, which is the mode of exposure most likely to occur in domestic setting, increases the potential for long-term, adverse health effects [11]. In our previous study, we mimicked dermal exposure condition in a rat model.…”